(Verbatim from the application): Heme oxygenase (HO) catalyzes the conversion of heme to biliverdin, free iron and carbon monoxide (GO). Heme is required for synthesis/activity of heme proteins that can affect vascular and renal function such as the eicosanoid biosynthetic enzymes, cytochrome P450 (GYP) monooxygenases, thromboxane and prostacyclin synthases and cyclooxygenases (COX). HO controls cellular heme concentrations and is solely responsible for the generation of the vasodepressor CO which, by itself, can bind to the heme moiety of heme proteins causing either enzyme activation or inhibition. Induction of HO suppresses renal arachidonic acid (AA) metabolism to pressor metabolites via GYP and COX/thromboxane synthase activities, is associated with natriuresis and blood pressure reduction, and is prevented by HO inhibitors, suggesting that HO-derived heme depletion and/or CO generation underlie these effects. CO or HOheme-generated CO elicits vasodilation in vitro and in vivo and reduces blood pressure in the SHR. Two HO isoforms have been identified as the primary source of HO activity, the inducible HO-i and the constitutively-expressed HO-2. The newly discovered HO-3 isoform share 90 percent homology with HO-2 and lack significant catalytic activity. The distribution and contribution of each isoform to HO activity within the kidney is unknown. We demonstrated relatively high levels of HO-2 in the renal microvessels and the medullary thick ascending limb, whereas proximal tubules exhibit high levels of HO-i. We propose that HO isoforms are differentially localized in kidney structures and contribute to the regulation of GYP and COX activities, thereby regulating the formation of eicosanoids that affect vasomotion and modulate ion transport. The proposed studies will: 1) localize HO isoforms expression and activity within the rat kidney; 2) examine the effect of HO inducers and selective inhibitors on HO isoforms expression and distribution in the kidney; and 3) study the effect of these maneuvers in determining the functional relationship of HO isoforms to renal COX and GYP-dependent eicosanoid biosynthesis. Studying HO in renal structures of normotensive and hypertensive rats and in rats in which renal HO has been altered will establish local changes in the expression of HO isoforms as they relate to the expression of COX and CYP-AA metabolism. Studies that examine the influence of HO activity on these heme proteins will shed light on possible mechanisms by which underexpression/overexpression of HO affects vascular tone, ion transport and blood pressure.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK056601-03
Application #
6628561
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Ketchum, Christian J
Project Start
2001-02-01
Project End
2005-01-31
Budget Start
2003-02-01
Budget End
2004-01-31
Support Year
3
Fiscal Year
2003
Total Cost
$281,700
Indirect Cost
Name
New York Medical College
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041907486
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Abraham, Nader G; Junge, Joshua M; Drummond, George S (2016) Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome. Trends Pharmacol Sci 37:17-36
Vanella, Luca; Canestraro, Martina; Lee, Craig R et al. (2015) Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis. Prostaglandins Other Lipid Mediat 120:139-47
Sodhi, K; Puri, N; Kim, D H et al. (2014) PPAR? binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats. Int J Obes (Lond) 38:456-65
Issan, Yossi; Kornowski, Ran; Aravot, Dan et al. (2014) Heme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stress. PLoS One 9:e92246
Hinds Jr, Terry D; Sodhi, Komal; Meadows, Charles et al. (2014) Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21. Obesity (Silver Spring) 22:705-12
Abraham, Nader G; Sodhi, Komal; Silvis, Anne M et al. (2014) CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype. Hypertension 64:1352-61
Monu, Sumit R; Pesce, Paola; Sodhi, Komal et al. (2013) HO-1 induction improves the type-1 cardiorenal syndrome in mice with impaired angiotensin II-induced lymphocyte activation. Hypertension 62:310-6
Vanella, Luca; Sodhi, Komal; Kim, Dong Hyun et al. (2013) Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt signaling cascade. Stem Cell Res Ther 4:28
Burgess, Angela P H; Vanella, Luca; Bellner, Lars et al. (2012) Heme oxygenase (HO-1) rescue of adipocyte dysfunction in HO-2 deficient mice via recruitment of epoxyeicosatrienoic acids (EETs) and adiponectin. Cell Physiol Biochem 29:99-110
Sodhi, Komal; Puri, Nitin; Inoue, Kazuyoshi et al. (2012) EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels. Prostaglandins Other Lipid Mediat 98:133-42

Showing the most recent 10 out of 47 publications